117 related articles for article (PubMed ID: 22170576)
1. Molecular analysis of mitochondrial compromise in rodent cardiomyocytes exposed long term to nucleoside reverse transcriptase inhibitors (NRTIs).
Liu Y; Nguyen P; Baris TZ; Poirier MC
Cardiovasc Toxicol; 2012 Jun; 12(2):123-34. PubMed ID: 22170576
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocytes are Protected from Antiretroviral Nucleoside Analog-Induced Mitochondrial Toxicity by Overexpression of PGC-1α.
Liu Y; Shim E; Crespo-Mejias Y; Nguyen P; Gibbons A; Liu D; Shide E; Poirier MC
Cardiovasc Toxicol; 2015 Jul; 15(3):224-31. PubMed ID: 25377427
[TBL] [Abstract][Full Text] [Related]
3. Tempol protects cardiomyocytes from nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
Liu Y; Shim E; Nguyen P; Gibbons AT; Mitchell JB; Poirier MC
Toxicol Sci; 2014 May; 139(1):133-41. PubMed ID: 24591154
[TBL] [Abstract][Full Text] [Related]
4. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
[TBL] [Abstract][Full Text] [Related]
5. Erythrocebus patas monkey offspring exposed perinatally to NRTIs sustain skeletal muscle mitochondrial compromise at birth and at 1 year of age.
Divi RL; Leonard SL; Walker BL; Kuo MM; Shockley ME; St Claire MC; Nagashima K; Harbaugh SW; Harbaugh JW; Poirier MC
Toxicol Sci; 2007 Sep; 99(1):203-13. PubMed ID: 17545213
[TBL] [Abstract][Full Text] [Related]
6. Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs).
Divi RL; Einem TL; Fletcher SL; Shockley ME; Kuo MM; St Claire MC; Cook A; Nagashima K; Harbaugh SW; Harbaugh JW; Poirier MC
Toxicol Sci; 2010 Nov; 118(1):191-201. PubMed ID: 20702595
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
Meng Q; Su T; O'Neill JP; Walker VE
Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
[TBL] [Abstract][Full Text] [Related]
8. Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to Zidovudine.
Divi RL; Haverkos KJ; Humsi JA; Shockley ME; Thamire C; Nagashima K; Olivero OA; Poirier MC
Environ Mol Mutagen; 2007; 48(3-4):179-89. PubMed ID: 16894629
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors.
Venhoff N; Setzer B; Melkaoui K; Walker UA
Antivir Ther; 2007; 12(7):1075-85. PubMed ID: 18018766
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside reverse transcriptase inhibitors (NRTIs)-induced expression profile of mitochondria-related genes in the mouse liver.
Desai VG; Lee T; Delongchamp RR; Leakey JE; Lewis SM; Lee F; Moland CL; Branham WS; Fuscoe JC
Mitochondrion; 2008 Mar; 8(2):181-95. PubMed ID: 18313992
[TBL] [Abstract][Full Text] [Related]
11. Cardiac mitochondrial compromise in 1-yr-old Erythrocebus patas monkeys perinatally-exposed to nucleoside reverse transcriptase inhibitors.
Divi RL; Leonard SL; Kuo MM; Walker BL; Orozco CC; St Claire MC; Nagashima K; Harbaugh SW; Harbaugh JW; Thamire C; Sable CA; Poirier MC
Cardiovasc Toxicol; 2005; 5(3):333-46. PubMed ID: 16244378
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial and metabolic effects of nucleoside reverse transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments.
Note R; Maisonneuve C; Lettéron P; Peytavin G; Djouadi F; Igoudjil A; Guimont MC; Biour M; Pessayre D; Fromenty B
Antimicrob Agents Chemother; 2003 Nov; 47(11):3384-92. PubMed ID: 14576092
[TBL] [Abstract][Full Text] [Related]
13. Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells.
Olivero OA; Tejera AM; Fernandez JJ; Taylor BJ; Das S; Divi RL; Poirier MC
Mutagenesis; 2005 Mar; 20(2):139-46. PubMed ID: 15784690
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine.
Gerschenson M; Nguyen V; Ewings EL; Ceresa A; Shaw JA; St Claire MC; Nagashima K; Harbaugh SW; Harbaugh JW; Olivero OA; Divi RL; Albert PS; Poirier MC
AIDS Res Hum Retroviruses; 2004 Jan; 20(1):91-100. PubMed ID: 15000702
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial and Oxidative Stress Response in HepG2 Cells Following Acute and Prolonged Exposure to Antiretroviral Drugs.
Nagiah S; Phulukdaree A; Chuturgoon A
J Cell Biochem; 2015 Sep; 116(9):1939-46. PubMed ID: 25740676
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders.
Hung KM; Chen PC; Hsieh HC; Calkins MJ
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):406-413. PubMed ID: 27840304
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.
Chan SS; Santos JH; Meyer JN; Mandavilli BS; Cook DL; McCash CL; Kissling GE; Nyska A; Foley JF; van Houten B; Copeland WC; Walker VE; Witt KL; Bishop JB
Environ Mol Mutagen; 2007; 48(3-4):190-200. PubMed ID: 16395692
[TBL] [Abstract][Full Text] [Related]
18. Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells.
Carter MM; Torres SM; Cook DL; McCash CL; Yu M; Walker VE; Walker DM
Environ Mol Mutagen; 2007; 48(3-4):239-47. PubMed ID: 17358029
[TBL] [Abstract][Full Text] [Related]
19. Long-term exposure to AZT, but not d4T, increases endothelial cell oxidative stress and mitochondrial dysfunction.
Kline ER; Bassit L; Hernandez-Santiago BI; Detorio MA; Liang B; Kleinhenz DJ; Walp ER; Dikalov S; Jones DP; Schinazi RF; Sutliff RL
Cardiovasc Toxicol; 2009 Mar; 9(1):1-12. PubMed ID: 19067249
[TBL] [Abstract][Full Text] [Related]
20. WR1065 mitigates AZT-ddI-induced mutagenesis and inhibits viral replication.
Walker DM; Kajon AE; Torres SM; Carter MM; McCash CL; Swenberg JA; Upton PB; Hardy AW; Olivero OA; Shearer GM; Poirier MC; Walker VE
Environ Mol Mutagen; 2009 Jul; 50(6):460-72. PubMed ID: 19334055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
